Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Área temáticas
Medicina y salud(2)
Medicina forense; incidencia de enfermedades(1)
Microorganismos, hongos y algas(1)
Origen
scopus(2)
COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study
ArticleAbstract: The Delta (B.1.617.2) variant was the predominant UK circulating SARS-CoV-2 strain between May and DPalabras claves:Autores:Aanensen D.M., Abudahab K., Adams A., Adams H., Afifi S., Aggarwal D., Ahmad S.S.Y., Aigrain L., Alcolea-Medina A., Alikhan N.F., Allara E., Amato R., Angyal A., Annett T., Antonelli M., Aplin S., Ariani C.V., Asad H., Ash A., Ashfield P., Ashford F., Atkinson L., Attwood S.W., Auckland C., Aydin A., Baker D.J., Baker P., Balcazar C.E., Ball J., Barrett J.C., Barrow M., Barton E., Bashton M., Bassett A.R., Batra R., Baxter C., Bayzid N., Beaver C., Beckett A.H., Beckwith S.M., Bedford L., Beer R., Beggs A., Bellis K.L., Bernardo M. Gutierrez, Berry L., Bertolusso B., Best A., Betteridge E., Bibby D., Bicknell K., Binns D., Birchley A., Bird P.W., Bishop C., Blacow R., Blakey V., Blane B., Bolt F., Bonfield J., Bonner S., Bonsall D., Boswell T., Bosworth A., Bourgeois Y., Boyd O., Bradley D.T., Breen C., Bresner C., Breuer J., Bridgett S., Bronner I.F., Brooks E., Broos A., Brown J.R., Bucca G., Buchan S.L., Buck D., Bull M., Burns P.J., Burton-Fanning S., Byaruhanga T., Byott M., Campbell S., Canas L.S., Capdevila J., Carabelli A.M., Cargill J.S., Carlile M., Carvalho S.F., Chen L., Deng J., Fox B., Graham M.S., Kerfoot E., Kläser K., May A., Molteni E., Murray B., Österdahl M.F., Wolf J.Fuentes:scopusRecurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
ArticleAbstract: We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70 in multiple inPalabras claves:Alpha variant, antibody escape, B.1.1.7, covid-19, deletion, infectivity, neutralizing antibodies, RESISTANCE, SARS-COV-2, spike mutationAutores:Aanensen D.M., Aggarwal D., Alderton A., Amato R., Andersson M.I., Ariani C.V., Awan A.R., Barrett J., Bashton M., Bassett A.R., Bernardo M. Gutierrez, Bonsall D., Bucca G., Bull M., Chand M., Chapman M.H.S., Chauhan A.J., Collier D.A., Connor T.R., Constantinidou C., Corden S., Cottrell S., Curran M.D., Darby A.C., Datir R.P., de Silva T.I., Dewar R., Elliott S., Fairley D.J., Ferreira I.A.T.M., Gallo G., Glaysher S., Golubchik T., Goncalves S., Hamilton W.L., Harrison E.M., Harvey W.T., Hassan-Ibrahim M.O., Hiscox J.A., Holden M.T.G., Jackson D.K., Jahun A.S., Jesudason N.G., Johnston I., Kemp S.A., Kwiatkowski D.P., Langford C.F., Lawniczak M., Li K.K., Livett R., Loman N.J., Loose M.W., Loveson K.F., Lowe H., Ludden C., Lytras S., Marelli S., Martincorena I., Martinez Nunez R.T., McCann C.M., McHugh M.P., McKenna J.P., McMurray C., Meng B., Mlcochova P., Mohamed A., Moore C., Moses S., Nelson A., Nicholls S.M., Osman H., O’Grady J., Pacchiarini N., Page A.J., Pandey S., Papa G., Parker M.D., Parmar S., Paterson S., Prieto J.A., Pybus O.G., Rambaut A., Robson S.C., Saeed K., Shah R.N., Shepherd J.G., Sillitoe J., Smith C.P., Smith D.L., Snell L.B., Taha Y., Templeton K.E., Thakur N., Thomson E.C., Torok M.E., Underwood A.P., Unnikrishnan M., Volz E.M., Wang D., Watkins J., Young G.R.Fuentes:scopus